Susquehanna International Group
INBX icon

Susquehanna International Group’s Inhibrx INBX Stock Holding History

Susquehanna International Group’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$450K Sell
6,700
-203,500
-97% -$15.1M ﹤0.01% 9945
2025
Q4 		$16.6M Buy
+210,200
New +$14.3M ﹤0.01% 2410
2025
Q1 		– Sell
-11,500
Closed -$177K – 12936
2024
Q4 		$177K Sell
11,500
-2,600
-18% -$39.6K ﹤0.01% 10861
2024
Q3 		$221K Buy
14,100
+500
+4% +$7.03K ﹤0.01% 10259
2024
Q2 		$193K Buy
+13,600
New +$212K ﹤0.01% 10413

Other funds holding INBX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Susquehanna International Group's INBX Position: Q1 2026 in Review

Susquehanna International Group reduced its Inhibrx (INBX) stake by 67% in Q1 2026, selling an estimated $14.8M and leaving 97,873 shares worth $6.58M. The position accounts for ﹤0.01% of the portfolio, ranked #3778.

Susquehanna International Group first reported a position in INBX in Q2 2024 and has held it in 7 quarters since. The position peaked at $23.5M in Q4 2025. 135 funds tracked by Wall St. Rank hold INBX as of Q1 2026.

  • Susquehanna International Group held 97,873 shares of Inhibrx worth $6.58M as of Q1 2026.
  • Susquehanna International Group sold 199,243 Inhibrx shares in Q1 2026, an estimated $14.8M.
  • Inhibrx made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #3778 holding.
  • Susquehanna International Group first reported a position in Inhibrx in Q2 2024 and has held it in 7 quarters since.
  • Susquehanna International Group's Inhibrx position peaked at $23.5M in Q4 2025.
  • 135 funds tracked by Wall St. Rank held Inhibrx as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.